12 May 2010 – broker buy note

It is good to see that broker Seymour Pierce has started coverage of the wound care products company with a buy rating and a 50p price target.  The broker thinks that the company is often overlooked by investors despite the fact it operates in a $15bn market.  Although the bid talks with Consort Medical broke down a few weeks ago, further approaches are possible.  We re-iterate our recommendation of BUY.